(Q38804978)

6 September 2017

1 reference

title

New strategies for improving stem cell therapy in ischemic heart disease (English)

1 reference

6 September 2017

Peisen Huang

1

1 reference

6 September 2017

Xiaqiu Tian

series ordinal

2

1 reference

6 September 2017

Qing Li

series ordinal

3

1 reference

6 September 2017

Yuejin Yang

series ordinal

4

1 reference

6 September 2017

publication date

26 July 2016

1 reference

6 September 2017

published in

Heart Failure Reviews

1 reference

6 September 2017

volume

21

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

737-752

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-016-9576-1

6 September 2017

exact match

0 references

cites work

Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Evidence for cardiomyocyte renewal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Stem cell therapy for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Stem-cell-based therapy and lessons from the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiac stem cell therapy and the promise of heart regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Meta-analysis of cell therapy trials for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiac stem cell therapy: Have we put too much hype in which cell type to use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal S

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cellular antioxidant levels influence muscle stem cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Hypoxia-inducible factor as a therapeutic target for cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

A short history of a short RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

MicroRNAs: key regulators of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

MicroRNAs in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Exosomes: immune properties and potential clinical implementations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Membrane vesicles as conveyors of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Regulation of immune responses by extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Stem cells: insights into the secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Exosomes as critical agents of cardiac regeneration triggered by cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Novel minicircle vector for gene therapy in murine myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Biomaterials for the Treatment of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Patching the heart: cardiac repair from within and outside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Materials science and tissue engineering: repairing the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Engineering hydrogels as extracellular matrix mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Electrical stimulation directs engineered cardiac tissue to an age-matched native phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Mimicking isovolumic contraction with combined electromechanical stimulation improves the development of engineered cardiac constructs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Biomaterials for the treatment of myocardial infarction: a 5-year update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Transplantation of Marrow-Derived Cardiac Stem Cells Carried in Fibrin Improves Cardiac Function After Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Bone marrow stem cells implantation with alpha-cyclodextrin/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Heart regeneration after myocardial infarction using synthetic biomaterials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Theoretical impact of the injection of material into the myocardium: a finite element model simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Injectable acellular hydrogels for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Pharmacologically active microcarriers: a tool for cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Historical markers in the development of allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Immunologic and inflammatory reactions to exogenous stem cells implications for experimental studies and clinical trials for myocardial repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Immunogenicity of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Preserving prostaglandin E2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores postinfarction ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Induced pluripotent stem cells: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Steps toward safe cell therapy using induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

To be immunogenic, or not to be: that's the iPSC question

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cells derived from iPSC can be immunogenic - yes or no?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Natural immunity to pluripotency antigen OCT4 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Banking on iPSC--is it doable and is it worthwhile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

A more efficient method to generate integration-free human iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

The distribution of HLA-A, -B, and -DRB1 alleles and haplotypes in inhabitants of Guizhou Province of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Transient regenerative potential of the neonatal mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Extending the time window of mammalian heart regeneration by thymosin beta 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Cardiopoietic Stem Cell Therapy in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Effects of Adipose Tissue-Derived Stem Cell Therapy After Myocardial Infarction: Impact of the Route of Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9576-1

Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration

21 January 2018

1 reference

12 December 2020

Endothelial Microparticle–Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles

1 reference

12 December 2020

Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo

1 reference

12 December 2020

Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials

1 reference

12 December 2020

Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles

1 reference

12 December 2020

Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching

1 reference

12 December 2020

Soluble factors from multipotent mesenchymal stromal cells have antinecrotic effect on cardiomyocytes in vitro and improve cardiac function in infarcted rat hearts

1 reference

12 December 2020

Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury.

1 reference

12 December 2020

Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair.

1 reference

12 December 2020

Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.

1 reference

12 December 2020

Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.

1 reference

12 December 2020

Atorvastatin induces autophagy of mesenchymal stem cells under hypoxia and serum deprivation conditions by activating the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway.

1 reference

12 December 2020

Cardiac grafting of engineered heart tissue in syngenic rats.

1 reference

12 December 2020

Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival

1 reference

12 December 2020

Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction

1 reference

12 December 2020

111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model.

1 reference

12 December 2020

Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

1 reference

12 December 2020

Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel

1 reference

12 December 2020

Role of WNT/β-catenin signaling in rejuvenating myogenic differentiation of aged mesenchymal stem cells from cardiac patients

1 reference

12 December 2020

Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart.

1 reference

12 December 2020

Transport of microRNAs via exosomes

1 reference

12 December 2020

Cardiac biointerventions: whatever happened to stem cell and gene therapy?

1 reference

12 December 2020

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction

1 reference

12 December 2020

10.1007/S10741-016-9576-1

Identifiers

DOI

1 reference

6 September 2017

1 reference